BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21348825)

  • 1. Matter of life and death: the pharmacological approaches targeting apoptosis in brain diseases.
    Cavallucci V; D'Amelio M
    Curr Pharm Des; 2011; 17(3):215-29. PubMed ID: 21348825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances of researches on caspases in neurodegenerative diseases].
    Xue H; Fang X; Wang W; Gao G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Apr; 30(2):438-42. PubMed ID: 23858776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis: a target for neuroprotection.
    Charriaut-Marlangue C
    Therapie; 2004; 59(2):185-90. PubMed ID: 15359610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fucoidan: a promising agent for brain injury and neurodegenerative disease intervention.
    Wang Y; Wang Q; Han X; Ma Y; Zhang Z; Zhao L; Guan F; Ma S
    Food Funct; 2021 May; 12(9):3820-3830. PubMed ID: 33861265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection in progressive brain disorders.
    Djaldetti R; Lev N; Melamed E
    Isr Med Assoc J; 2003 Aug; 5(8):576-80. PubMed ID: 12929297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiapoptotic drugs: a therapautic strategy for the prevention of neurodegenerative diseases.
    Sureda FX; Junyent F; Verdaguer E; Auladell C; Pelegri C; Vilaplana J; Folch J; Canudas AM; Zarate CB; Pallès M; Camins A
    Curr Pharm Des; 2011; 17(3):230-45. PubMed ID: 21348832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective estrogen receptor modulators as brain therapeutic agents.
    Arevalo MA; Santos-Galindo M; Lagunas N; Azcoitia I; Garcia-Segura LM
    J Mol Endocrinol; 2011 Feb; 46(1):R1-9. PubMed ID: 21071476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis: a key in neurodegenerative disorders.
    Ekshyyan O; Aw TY
    Curr Neurovasc Res; 2004 Oct; 1(4):355-71. PubMed ID: 16181084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects for antiapoptotic drug therapy of neurodegenerative diseases.
    Waldmeier PC
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):303-21. PubMed ID: 12657369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy and apoptosis dysfunction in neurodegenerative disorders.
    Ghavami S; Shojaei S; Yeganeh B; Ande SR; Jangamreddy JR; Mehrpour M; Christoffersson J; Chaabane W; Moghadam AR; Kashani HH; Hashemi M; Owji AA; Łos MJ
    Prog Neurobiol; 2014 Jan; 112():24-49. PubMed ID: 24211851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using sigma-ligands as part of a multi-receptor approach to target diseases of the brain.
    Brimson JM; Brimson S; Chomchoei C; Tencomnao T
    Expert Opin Ther Targets; 2020 Oct; 24(10):1009-1028. PubMed ID: 32746649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start.
    Veenman L
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.
    Karnati HK; Panigrahi MK; Gutti RK; Greig NH; Tamargo IA
    J Alzheimers Dis; 2015; 48(3):563-80. PubMed ID: 26402105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis in acute and chronic neurological disorders.
    Ekshyyan O; Aw TY
    Front Biosci; 2004 May; 9():1567-76. PubMed ID: 14977568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis in neurodegenerative disorders.
    Mattson MP
    Nat Rev Mol Cell Biol; 2000 Nov; 1(2):120-9. PubMed ID: 11253364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiapoptotic activity of melatonin in neurodegenerative diseases.
    Wang X
    CNS Neurosci Ther; 2009; 15(4):345-57. PubMed ID: 19818070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcuminoids in neurodegenerative diseases.
    Kim DS; Kim JY; Han Y
    Recent Pat CNS Drug Discov; 2012 Dec; 7(3):184-204. PubMed ID: 22742420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal death and neuroprotection: a review.
    Repici M; Mariani J; Borsello T
    Methods Mol Biol; 2007; 399():1-14. PubMed ID: 18309921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegenerative changes and neuroapoptosis induced by systemic lipopolysaccharide administration are reversed by dexmedetomidine treatment in mice.
    Ning Q; Liu Z; Wang X; Zhang R; Zhang J; Yang M; Sun H; Han F; Zhao W; Zhang X
    Neurol Res; 2017 Apr; 39(4):357-366. PubMed ID: 28173746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection by the inhibition of apoptosis.
    Robertson GS; Crocker SJ; Nicholson DW; Schulz JB
    Brain Pathol; 2000 Apr; 10(2):283-92. PubMed ID: 10764048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.